Genprex, Inc. GNPX
Set alert
2.24 USD +0.20 +9.80%
At close
2.24 0.00 0.00%
Pre-market · Nov 2, 4:32 AM ET
2.02 Day range 2.27
1.71 52-week range 138.60
- YTD
- -94.18%
- 1 year
- -98.38%
- Open
- 2.02
- Prev close
- 2.04
- Mkt cap
- 1.84M
- Vol
- 184.02K
- Avg vol
- 284.07K
- EPS
- -9.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.02
- High
- 2.27
- Forward P/E
- -0.43
- Beta
- -1.29
- Short ratio
- 0.02
- Inst. own
- 10.91%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 1.36
- 200-d avg
- 1.75
- 1y target
- 7.50
News
4 days ago prnewswire.com
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Research explores the role of TUSC2, the therapeutic gene used in Reqorsa® Gene Therapy in mitochondrial biology and cellular aging, supporting investigation of potential applications beyond oncology…
-
1 week ago benzinga.com
Genprex Highlights New Peer-Reviewed Research In Mice Identifying Important Role For TUSC2 Tumor Suppressor Gene In Maintaining Cellular Processes Associated With Healthy Brain Aging
Collaborators publish new peer-reviewed study identifying sex-specific effects of TUSC2 loss on mitochondrial function, protein homeostasis, and synaptic pathways, alongside molecular similarities…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 11.0% to $0.17 during Friday's after-market session. The company's market cap stands at $2.4 million. Lexaria Bioscience…